|
1
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Estimated number of cancer cases diagnosed
in women in Japan in 2020 by cancer site. Statista Research
Department; May 7–2021, www.statista.com/statistics/950381/japan-estimated-cancer-incidence-female-by-cancer-site/
|
|
3
|
Chalasani P: What are the prognostic and
predictive factors for breast cancer? Medscape. Feb
04–2021.www.medscape.com/answers/1947145-155277
|
|
4
|
Meguerditchian AN, Bairati I, Lagacé R,
Harel F and Kibrité A: Prognostic significance of lymphovascular
invasion in surgically cured rectal carcinoma. Am J Surg.
189:707–713. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lotan Y, Gupta A, Shariat SF, Palapattu
GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G,
Perotte P, et al: Lymphovascular invasion is independently
associated with overall survival, cause-specific survival, and
local and distant recurrence in patients with negative lymph nodes
at radical cystectomy. J Clin Oncol. 23:6533–6539. 2005. View Article : Google Scholar
|
|
6
|
Herman CM, Wilcox GE, Kattan MW, Scardino
PT and Wheeler TM: Lymphovascular invasion as a predictor of
disease progression in prostate cancer. Am J Surg Pathol.
24:859–863. 2000. View Article : Google Scholar
|
|
7
|
Stålberg K, Bjurberg M, Borgfeldt C,
Carlson J, Dahm-Kähler P, Flöter-Rådestad A, Hellman K, Hjerpe E,
Holmberg E, Kjølhede P, et al: Lymphovascular space invasion as a
predictive factor for lymph node metastases and survival in
endometrioid endometrial cancer-a Swedish gynecologic cancer group
(SweGCG) study. Acta Oncol. 58:1628–1633. 2019. View Article : Google Scholar
|
|
8
|
Teel P: Vascular invasion as a prognostic
factor in breast carcinoma. Surg Gynecol Obstet. 118:1006–1008.
1964.
|
|
9
|
Kai K, Nishimura R, Arima N, Miyayama H
and Iwase H: p53 expression status is a significant molecular
marker in predicting the time to endocrine therapy failure in
recurrent breast cancer: A cohort study. Int J Clin Oncol.
11:426–433. 2006. View Article : Google Scholar
|
|
10
|
Kikuchi S, Osako T, Nishiyama Y, Nakano M,
Tashima R, Fujisue M, Toyozumi Y and Arima N: P53 overexpression in
ductal carcinoma in situ of the breast. J Cytol Histol. 5:269–274.
2014.
|
|
11
|
Rakha EA, Martin S, Lee AH, Morgan D,
Pharoah PD, Hodi Z, Macmillan D and Ellis IO: The prognostic
significance of lymphovascular invasion in invasive breast
carcinoma. Cancer. 118:3670–3680. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hoda SA, Brogi E, Koerner FC and Rosen PP:
Rosen's Breast Pathology. fifth edition. Wolters Kluwer; pp.
p477–482. 2014
|
|
13
|
Arima N, Nishimura R, Osako T, Nishiyama
Y, Fujisue M, Okumura Y, Nakano M, Tashima R and Toyozumi Y: The
importance of tissue handling of surgically removed breast cancer
for an accurate assessment of the Ki-67 index. J Clin Pathol.
69:255–259. 2016. View Article : Google Scholar
|
|
14
|
Debled M, de Mascarel I, Brouste V,
Mauriac L and MacGrogan G: Re: Population-based study of
peritumoral lymphovascular invasion and outcome among patients with
operable breast cancer. J Natl Cancer Inst. 102:275–277. 2010.
View Article : Google Scholar
|
|
15
|
Ejlertsen B, Jensen MB, Rank F, Rasmussen
BB, Christiansen P, Kroman N, Kvistgaard ME, Overgaard M, Toftdahl
DB and Mouridsen HT; Danish Breast Cancer Cooperative Group, :
Population-based study of peritumoral lymphovascular invasion and
outcome among patients with operable breast cancer. J Natl Cancer
Inst. 101:729–735. 2009. View Article : Google Scholar
|
|
16
|
Chas M, Boivin L, Arbion F, Jourdan ML,
Body G and Ouldamer L: Clinicopathologic predictors of lymph node
metastasis in breast cancer patients according to molecular
subtype. J Gynecol Obstet Hum Reprod. 47:9–15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Houvenaeghel G, Cohen M, Classe JM, Reyal
F, Mazouni C, Chopin N, Martinez A, Daraï E, Coutant C, Colombo PE,
et al: Lymphovascular invasion has a significant prognostic impact
in patients with early breast cancer, results from a large,
national, multicenter, retrospective cohort study. ESMO Open.
6:1003162021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang S, Zhang D, Gong M, Wen L, Liao C
and Zou L: High lymphatic vessel density and presence of
lymphovascular invasion both predict poor prognosis in breast
cancer. BMC Cancer. 17:3352017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akrami M, Meshksar A, Ghoddusi JM,
Safarpour MM, Tahmasebi S, Zangouri V and Talei A: Prognostic role
of lymphovascular invasion in patients with early breast cancer.
Indian J Surg Oncol. 12:671–677. 2021. View Article : Google Scholar
|
|
20
|
Mohammed ZM, McMillan DC, Edwards J,
Mallon E, Doughty JC, Orange C and Going JJ: The relationship
between lymphovascular invasion and angiogenesis, hormone
receptors, cell proliferation and survival in patients with primary
operable invasive ductal breast cancer. BMC Clin Pathol. 13:312013.
View Article : Google Scholar
|
|
21
|
Mohammed RA, Martin SG, Mahmmod AM,
Macmillan RD, Green AR, Paish EC and Ellis IO: Objective assessment
of lymphatic and blood vascular invasion in lymph node-negative
breast carcinoma: Findings from a large case series with long-term
follow-up. J Pathol. 223:358–365. 2011. View Article : Google Scholar
|
|
22
|
Pinder SE, Ellis IO, Galea M, O'Rouke S,
Blamey RW and Elston CW: Pathological prognostic factors in breast
cancer. III. Vascular invasion: Relationship with recurrence and
survival in a large study with long-term follow-up. Histopathology.
24:41–47. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Freedman GM, Li T, Polli LV, Anderson PR,
Bleicher RJ, Sigurdson E, Swaby R, Dushkin H, Patchefsky A and
Goldstein L: Lymphatic space invasion is not an independent
predictor of outcomes in early stage breast cancer treated by
breast-conserving surgery and radiation. Breast J. 18:415–419.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ovcaricek T, Frkovic SG, Matos E, Mozina B
and Borstnar S: Triple negative breast cancer-prognostic factors
and survival. Radiol Oncol. 45:46–52. 2011. View Article : Google Scholar
|
|
25
|
Camp RL, Rimm EB and Rimm DL: A high
number of tumor free axillary lymph nodes from patients with lymph
node negative breast carcinoma is associated with poor outcome.
Cancer. 88:108–113. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim SH, Simkovich-Heerdt A, Tran KN,
Maclean B and Borgen PI: Women 35 years of age or younger have
higher locoregional relapse rates after undergoing breast
conservation therapy. J Am Coll Surg. 187:1–8. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Na YM, Ryu YJ, Cho JS, Park MH and Yoon
JH: Lymphovascular invasion as a predictive factor for recurrence
in triple-negative breast cancer. Indian J Surg. 83:475–483. 2021.
View Article : Google Scholar
|
|
28
|
Morkavuk ŞB, Güner M, Çulcu S, Eroğlu A,
Bayar S and Ünal AE: Relationship between lymphovascular invasion
and molecular subtypes in invasive breast cancer. Int J Clin Pract.
75:e138972021. View Article : Google Scholar
|
|
29
|
Hamy AS, Lam GT, Laas E, Darrigues L,
Balezeau T, Guerin J, Livartowski A, Sadacca B, Pierga JY,
Vincent-Salomon A, et al: Lymphovascular invasion after neoadjuvant
chemotherapy is strongly associated with poor prognosis in breast
carcinoma. Breast Cancer Res Treat. 169:295–304. 2018. View Article : Google Scholar
|
|
30
|
Ryu YJ, Kang SJ, Cho JS, Yoon JH and Park
MH: Lymphovascular invasion can be better than pathologic complete
response to predict prognosis in breast cancer treated with
neoadjuvant chemotherapy. Medicine (Baltimore). 97:e116472018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kariri YA, Aleskandarany MA, Joseph C,
Kurozumi S, Mohammed OJ, Toss MS, Green AR and Rakha EA: Molecular
complexity of lymphovascular invasion: The role of cell migration
in breast cancer as a prototype. Pathobiology. 87:218–231. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Asaoka M, Patnaik SK, Zhang F, Ishikawa T
and Takabe K: Lymphovascular invasion in breast cancer is
associated with gene expression signatures of cell proliferation
but not lymphangiogenesis or immune response. Breast Cancer Res
Treat. 181:309–322. 2020. View Article : Google Scholar
|
|
33
|
Kurozumi S, Joseph C, Sonbul S, Alsaeed S,
Kariri Y, Aljohani A, Raafat S, Alsaleem M, Ogden A, Johnston SJ,
et al: A key genomic subtype associated with lymphovascular
invasion in invasive breast cancer. Br J Cancer. 120:1129–1136.
2019. View Article : Google Scholar : PubMed/NCBI
|
